Tevogen Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
5.76
-0.54 (-8.51%)
Nov 20, 2026, 12:33 PM EST - Market open
Tevogen Market Cap
Tevogen has a market cap or net worth of $395.84 million as of November 20, 2026. It is the 15,348th most valuable company in the world and the 2,821st biggest in the United States. Its market cap has increased by 343.32% in one year.
Market Cap
395.84M
Enterprise Value
406.11M
1-Year Change
343.32%
Global Rank
Country Rank
#2,821 United States
Category
ChartMarket Cap Chart
Since January 5, 2022, Tevogen's market cap has decreased from $446.69M to $395.84M, a decrease of -11.38%. That is a compound annual growth rate of -2.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 395.84M | 501.71% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 95.39M |
| Retension Pharmaceuticals | 95.06M |
| Equillium | 94.82M |
| Vivani Medical | 94.71M |
| Voyager Therapeutics | 94.59M |
| Anixa Biosciences | 92.82M |
| PMV Pharmaceuticals | 92.13M |
| Nkarta | 89.63M |